Holders — by stockHoldings — by fund
Defilade Capital Management, L.P.
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0002088557
$746.9M
disclosed book value
39
positions
6.3%
largest position share
Positions, as of 2026-06-30
top 39 of 39 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | LLYELI LILLY & CO | 39,086 | $46.9M | 6.3% |
| 2 | PFEPFIZER INC | 1.8M | $42.7M | 5.7% |
| 3 | VEEVVEEVA SYS INC | 236,709 | $42.0M | 5.6% |
| 4 | BMRNBIOMARIN PHARMACEUTICAL INC | 682,005 | $39.0M | 5.2% |
| 5 | PTCTPTC THERAPEUTICS INC | 433,699 | $35.4M | 4.7% |
| 6 | BAXBAXTER INTL INC | 1.5M | $31.1M | 4.2% |
| 7 | INSMINSMED INC | 281,838 | $30.0M | 4% |
| 8 | ZBHZIMMER BIOMET HOLDINGS INC | 317,426 | $27.3M | 3.7% |
| 9 | PODDINSULET CORP | 176,932 | $26.9M | 3.6% |
| 10 | TMOTHERMO FISHER SCIENTIFIC INC | 51,934 | $26.0M | 3.5% |
| 11 | ABTABBOTT LABORATORIES | 285,778 | $25.9M | 3.5% |
| 12 | ASCENDIS PHARMA A/S | 94,843 | $25.3M | 3.4% |
| 13 | SOLVSOLVENTUM CORP | 316,454 | $24.4M | 3.3% |
| 14 | MEDTRONIC PLC | 303,301 | $23.7M | 3.2% |
| 15 | ELANELANCO ANIMAL HEALTH INC | 864,080 | $21.3M | 2.8% |
| 16 | AGIOAGIOS PHARMACEUTICALS INC | 546,848 | $20.3M | 2.7% |
| 17 | NVSTENVISTA HOLDINGS CORPORATION | 726,108 | $19.1M | 2.6% |
| 18 | RVMDREVOLUTION MEDICINES INC | 82,827 | $15.5M | 2.1% |
| 19 | ICUIICU MED INC | 105,700 | $15.5M | 2.1% |
| 20 | COGTCOGENT BIOSCIENCES INC | 393,441 | $15.2M | 2% |
| 21 | LNTHLANTHEUS HLDGS INC | 132,662 | $14.7M | 2% |
| 22 | OCULOCULAR THERAPEUTIX INC | 1.5M | $14.6M | 2% |
| 23 | ELDNELEDON PHARMACEUTICALS INC | 3.5M | $13.9M | 1.9% |
| 24 | TYRATYRA BIOSCIENCES INC | 376,870 | $12.0M | 1.6% |
| 25 | OLMAOLEMA PHARMACEUTICALS INC | 924,758 | $11.6M | 1.5% |
| 26 | ORICORIC PHARMACEUTICALS INC | 1.0M | $11.3M | 1.5% |
| 27 | LRMRLARIMAR THERAPEUTICS INC | 3.7M | $11.2M | 1.5% |
| 28 | GMEDGLOBUS MED INC | 139,637 | $11.0M | 1.5% |
| 29 | ENOVENOVIS CORPORATION | 531,945 | $11.0M | 1.5% |
| 30 | EVMNEVOMMUNE INC | 793,145 | $10.5M | 1.4% |
| 31 | TFXTELEFLEX INCORPORATED | 80,118 | $10.2M | 1.4% |
| 32 | DNLIDENALI THERAPEUTICS INC | 391,866 | $10.1M | 1.3% |
| 33 | GKOSGLAUKOS CORP | 66,519 | $9.3M | 1.2% |
| 34 | STAASTAAR SURGICAL CO | 322,126 | $9.2M | 1.2% |
| 35 | PACSPACS GROUP INC | 215,675 | $9.2M | 1.2% |
| 36 | CRNXCRINETICS PHARMACEUTICALS IN | 239,440 | $9.0M | 1.2% |
| 37 | LIVANOVA PLC | 107,373 | $8.8M | 1.2% |
| 38 | BDTXBLACK DIAMOND THERAPEUTICS I | 1.7M | $3.1M | 0.4% |
| 39 | MREOMEREO BIOPHARMA GROUP PLC | 7.6M | $2.4M | 0.3% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.